WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to see how safe and effective and tolerable the use of
colesevelam hydrochloride is for type 2 diabetes when added to sulfonylurea alone or in
combination with other anti-diabetic drugs.